{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01257776",
      "NCTIdAliasList": {
        "NCTIdAlias": [
          "NCT01079403"
        ]
      },
      "OrgStudyIdInfo": {
        "OrgStudyId": "CeTMAd/ICPD/2008"
      },
      "Organization": {
        "OrgFullName": "Andalusian Network for Design and Translation of Advanced Therapies",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients",
      "OfficialTitle": "Using Mesenchymal Stem Cells From Adipose Tissue (CeTMAd) as Cell Regeneration Therapy in Chronic Ischemic Syndrome of Lower Limbs in Diabetic Patients"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2014",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "December 2010"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "February 2013",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "July 2015",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "December 9, 2010",
      "StudyFirstSubmitQCDate": "December 9, 2010",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 10, 2010",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "August 4, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 5, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Iniciativa Andaluza en Terapias Avanzadas",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "A prospective, multicenter, open, randomized, parallel-group controlled study for two levels of dose.\n\nThe study population will consist of 30 non-diabetic patients with critical chronic ischemia in at least one of the lower limbs (CLI) and without possibility of revascularization, from whom results can clinically be evaluable, of whom, 20 patients will be included in the experimental group (10 for each dose level) and 10 in the control group.\n\nIn each of the two dose levels to be used in the study, 15 patients will be included, who will be randomized to the experimental group or the control group according to a distribution 2:1 (2 patients in the experimental group and 1 in control group), thus at each dose level, we will have 10 patients in the experimental group (treated with mesenchymal cells of adipose tissue) and 5 patients in the control group (conventional treatment)"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Critical Limb Ischemia (CLI)",
          "Diabetes"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Critical Limb Ischemia (CLI)",
          "Diabetes",
          "Mesenchymal Stem Cells",
          "Regenerative Therapy"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "33",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stem cells 0,5 million * weight (kg)",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Group of low dose of Mesenchymal stem cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Autologous adipose derived mesenchymal stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Mesenchymal stem cells 1 million * weight (kg)",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Group of mid dose of mesenchymal stem cells",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Autologous adipose derived mesenchymal stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Controlled group",
            "ArmGroupType": "No Intervention",
            "ArmGroupDescription": "Controlled group with no intervention"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Autologous adipose derived mesenchymal stem cells",
            "InterventionDescription": "Intra-arterial administration through a selective cannulation of target common femoral artery",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cells 0,5 million * weight (kg)",
                "Mesenchymal stem cells 1 million * weight (kg)"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Angiographic assessment of neovasculogenesis (angiogenesis plus arteriogenesis)",
            "PrimaryOutcomeDescription": "Target limb vascularization would be quantified by a dedicated software, MetaMorph® v.6.3, by using Angiogenesis Tube Formation application module. Neovasculogenesis would be the difference between vascularization at baseline and 6 months follow-up.",
            "PrimaryOutcomeTimeFrame": "6 months"
          },
          {
            "PrimaryOutcomeMeasure": "Major adverse event (death, target limb amputation)",
            "PrimaryOutcomeTimeFrame": "1 month, 6 months, 12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Ankle Brachial Index",
            "SecondaryOutcomeTimeFrame": "1 month, 6 months, 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "University of Texas Classification at target limb",
            "SecondaryOutcomeTimeFrame": "1 month, 6 months, 12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiabetes, type 1 or 2\nCritical Limb Ischemia (Rutherford Becker Class II,III or IV)of at least one limb.\nNo options for target limb revascularization.\n\nExclusion Criteria:\n\nCancer antecedent in the last two years\nCurrent limb infection or limb gangrene",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "85 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Rafael J Ruiz-Salmeron, MD, PhD",
            "OverallOfficialAffiliation": "University Hospital Virgen Macarena. Seville.Spain",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Antonio De la Cuesta, MD",
            "OverallOfficialAffiliation": "University Hospital Virgen Macarena. Seville.Spain",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University Hospital Virgen Macarena",
            "LocationCity": "Seville",
            "LocationZip": "41007",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine)",
            "LocationCity": "Seville",
            "LocationZip": "41092",
            "LocationCountry": "Spain"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M6267",
            "ConditionBrowseLeafName": "Diabetes Mellitus",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M15507",
            "ConditionBrowseLeafName": "Syndrome",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemia",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC19",
            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}